A pan-HER approach for cancer therapy: background, current status and future development

Author： Huang Zhongdong   Brdlik Cathleen   Jin Pei   Shepard H Michael  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.9, Iss.1, 2009-01, pp. : 97-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450-based cancer gene therapy: current status

By Kan On   Kingsman Susan   Naylor Stuart  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 857-868

Informa Healthcare

Access to resources Recommend Favorite

Biosimilars: current status and future directions

By Roger Simon D  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1011-1018

Informa Healthcare

Access to resources Recommend Favorite

HER2 as a target for breast cancer therapy

By Tagliabue Elda   Balsari Andrea   Campiglio Manuela   Pupa Serenella M  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 711-724

Informa Healthcare

Access to resources Recommend Favorite

Current status of biodiesel development in Brazil

By Ramos Luiz   Wilhelm Helena  

Applied Biochemistry and Biotechnology, Vol. 123, Iss. 1-3, 2005-03 ,pp. : 807-819

Humana Press, Inc

Access to resources Recommend Favorite

Islet transplantation for diabetes: current status and future prospects

By Emerich Dwaine F  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 793-803

Informa Healthcare

Access to resources Recommend Favorite